The global Cell & Gene Therapy Manufacturing Services market, valued at USD 11.4 billion in 2023, is poised for remarkable growth and is projected to reach USD 70.7 billion by 2032, expanding at a compound annual growth rate (CAGR) of 22.4% from 2024 to 2032. The rapid expansion of the market is driven by the increasing demand for advanced therapies, substantial investments in research and...